End-zit
Sulfur
Abbe Laboratories, Inc.
Human Otc Drug
NDC 68605-2002End-zit also known as Sulfur is a human otc drug labeled by 'Abbe Laboratories, Inc.'. National Drug Code (NDC) number for End-zit is 68605-2002. This drug is available in dosage form of Lotion, Augmented. The names of the active, medicinal ingredients in End-zit drug includes Sulfur - .05 g/g . The currest status of End-zit drug is Active.
Drug Information:
Drug NDC: | 68605-2002 |
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC. |
Proprietary Name: | End-zit |
Also known as the trade name. It is the name of the product chosen by the labeler. |
Product Type: | Human Otc Drug |
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing. |
Non Proprietary Name: | Sulfur |
Also known as the generic name, this is usually the active ingredient(s) of the product. |
Labeler Name: | Abbe Laboratories, Inc. |
Name of Company corresponding to the labeler code segment of the ProductNDC. |
Dosage Form: | Lotion, Augmented |
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources. |
Status: | Active |
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved. |
Substance Name: | SULFUR - .05 g/g
|
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted. |
Route Details: | TOPICAL
|
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
Marketing Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Marketing Category: | OTC MONOGRAPH FINAL |
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
Marketing Start Date: | 20 Apr, 2004 |
This is the date that the labeler indicates was the start of its marketing of the drug product. |
Marketing End Date: | 15 Jan, 2025 |
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached. |
Application Number: | part333D |
This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null. |
Listing Expiration Date: | 31 Dec, 2023 |
This is the date when the listing record will expire if not updated or certified by the firm. |
OpenFDA Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Manufacturer Name: | ABBE Laboratories, Inc.
|
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC. |
RxCUI: | 422938 1094323
|
The RxNorm Concept Unique Identifier. RxCUI is a unique number that describes a semantic concept about the drug product, including its ingredients, strength, and dose forms. |
Original Packager: | Yes
|
Whether or not the drug has been repackaged for distribution. |
UNII: | 70FD1KFU70
|
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information. |
Packaging Information:
Package NDC | Description | Marketing Start Date | Marketing End Date | Sample Available |
---|
68605-2002-2 | 17.57 g in 1 BOTTLE, GLASS (68605-2002-2) | 20 Apr, 2004 | N/A | No |
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together. |
Purpose:
Purpose ............. acne treatment
Product Elements:
End-zit sulfur sulfur sulfur isopropyl alcohol water zinc oxide propylene glycol camphor (synthetic) talc sodium laureth sulfate titanium dioxide diazolidinyl urea methylparaben propylparaben light/medium end-zit sulfur sulfur sulfur isopropyl alcohol water zinc oxide propylene glycol camphor (synthetic) talc sodium laureth sulfate titanium dioxide diazolidinyl urea methylparaben propylparaben medium/dark end-zit sulfur sulfur sulfur isopropyl alcohol water zinc oxide propylene glycol camphor (synthetic) talc sodium laureth sulfate titanium dioxide diazolidinyl urea methylparaben propylparaben mask
Indications and Usage:
Intended for use on blemishes only. this advanced formulation is designed to dry and aid in elimination of pimples. it is make-up quality for excellent coverage of the blemish. it is unbelievably effective, clinically tested, dermatologist approved and recommended.
Warnings:
Warnings: for external use only. using other topical acne medications at the same time or immediately following use of this product may increase dryness or irritation of the skin. if this occurs, only one medication should be used unless directed by a doctor. do not get into eyes. if excessive skin irritation deve lops or increases, discontinue use and consult a doctor.
Do Not Use:
Warnings: for external use only. using other topical acne medications at the same time or immediately following use of this product may increase dryness or irritation of the skin. if this occurs, only one medication should be used unless directed by a doctor. do not get into eyes. if excessive skin irritation deve lops or increases, discontinue use and consult a doctor.
Dosage and Administration:
Directions: shake bottle well before each use. apply directly to blemish only, using applicator. wait a few moments until slightly dry. pat with fingertip or clean cotton swab to blend color to skin. make-up may be applied if desired. should remain on skin all day. re-apply at night to clean skin to remain on skin overnight.
Package Label Principal Display Panel:
package label.principal disply panel directions: shake bottle well. apply twice daily directly to acne breakout. allow to dry for 10 seconds. pat to blend. apply make-up if desired. active ingredient: sulfur 5%. warnings: avoid if allergic to sulfur avoid contact with eyes for external use only keep from children manufactured by abbe laboratories, inc. farmingdale, ny 11735 made in the u.s.a. end-zit® acne control drying lotion abbe 0.62 oz. (17.57 g) product label
package label.principal disply panel directions: shake bottle well. apply twice daily directly to acne breakout. allow to dry for 10 seconds. pat to blend. apply make-up if desired. active ingredient: sulfur 5%. warnings: avoid if allergic to sulfur avoid contact with eyes for external use only keep from children manufactured by abbe laboratories, inc. farmingdale, ny 11735 made in the u.s.a. end-zit® acne control drying lotion abbe 0.62 oz. (17.57 g) product label
package label.principal disply panel directions: shake bottle well. apply twice daily directly to acne breakout. allow to dry for 10 seconds. pat to blend. apply make-up if desired. active ingredient: sulfur 5%. warnings: avoid if allergic to sulfur avoid contact with eyes for external use only keep from children manufactured by abbe laboratories, inc. farmingdale, ny 11735 made in the u.s.a. end-zit® acne control drying lotion abbe 0.62 oz. (17.57 g) product label